| 12/17/2018 | HY | Market Commentary: Morning Commentary: Hospitals, pharmaceuticals trade lower in wake of ACA ruling in Texas
|
| 11/9/2018 | BKCAHY | S&P affirms Bausch Health
|
| 11/7/2018 | CAHYLM | Bausch Health tenders, solicits consents for 7½% notes due 2021
|
| 8/28/2018 | HY | Market Commentary: Morning Commentary: Junk opens unchanged in thin trading; funds see Monday inflows
|
| 8/23/2018 | BKCADDHY | Moody’s ups Bausch SGL, changes view
|
| 6/20/2018 | HY | Market Commentary: Intelsat dominates trading; PHI recoups losses; Valeant Pharmaceuticals active
|
| 6/1/2018 | CAHYLM | Valeant to redeem 5 3/8%, 6 3/8%, 6¾%, 7¼% senior notes on July 2
|
| 5/25/2018 | HY | Market Commentary: Primary market quiet pre-holiday; forward calendar light; California Resources in focus
|
| 5/22/2018 | HY | Market Commentary: JW Aluminum prices; Carriage Services, Tervita on tap; Mattel off on add-on; PetSmart in focus
|
| 5/21/2018 | HY | Market Commentary: Graham Holdings, Atotech on tap; Ithaca Energy, JW Aluminum delayed; EP Energy dominates
|
| 5/18/2018 | HY | Market Commentary: EP Energy, BWX prices; Valeant trades up; Hearthside, SRS struggle; Sprint tanks
|
| 5/18/2018 | HY | Market Commentary: Morning Commentary: EP Energy, BWX Technologies offerings on deck; new Valeant notes trade up
|
| 5/17/2018 | HY | Market Commentary: Valeant, Hearthside, SRS, others price; GFL, WeWork struggle again; funds lose $542 million
|
| 5/17/2018 | CAHY | New Issue: Valeant prices $750 million 8.6-year notes at par to yield 8½%
|
| 5/17/2018 | BKCADDHY | Moody’s rates Valeant notes Caa1
|
| 5/17/2018 | CAHY | Valeant talks $750 million 8.6-year notes to yield in 8 5/8% area; pricing Thursday
|
| 5/17/2018 | CAHY | Valeant debt refinancing to include $750 million new 8.6-year notes coming in Thursday drive-by
|
| 5/16/2018 | CLHY | Market Commentary: Summit, Jordan, Berry break; Valeant, Quest, Omnia, Pinnacle, Hillman and more updated
|
| 5/15/2018 | BKCAHY | Moody’s rates Valeant loans Ba3
|
| 5/14/2018 | CLHY | Market Commentary: Jordan Health, BI-LO, Power Products revised; Valeant, Telenet, Open Text, more set talk
|
| 5/14/2018 | BKCAHY | S&P rates Valeant loans BB-, notes B-
|
| 5/11/2018 | HY | Market Commentary: Forward calendar fills up; Gaming & Leisure, Centene improve; Ultra drops on earnings
|
| 5/10/2018 | HY | Market Commentary: Nemaska prices; Hearthside, Valeant join calendar; MDC tanks; funds add $0.76 billion
|
| 5/10/2018 | CLHY | Market Commentary: Aristocrat, GFL, Bright Horizons break; Vistra Energy, American Airlines, TerraForm update
|
| 5/10/2018 | HY | Market Commentary: Morning Commentary: MDC Partners bonds crater on dismal earnings; Wednesday deals trade higher
|
| 5/10/2018 | CAHY | Valeant Pharmaceuticals refinancing to include $750 million secured, $750 million unsecured notes
|
| 5/8/2018 | HY | Market Commentary: Primary quiet; Gaming & Leisure active; Dish bonds volatile; Sanchez Energy drops, Valeant gains on earnings
|
| 5/8/2018 | BKBWCAHYLM | Valeant cuts debt by $6.9 billion since 2016; ‘more work to be done’
|
| 4/12/2018 | CAHYLM | Valeant plans to redeem $150 million 6 3/8% senior notes on May 14
|
| 4/10/2018 | CAHYLM | Valeant Pharmaceuticals wraps tender offers for three series of notes
|
| 3/26/2018 | CAHYLM | Valeant receives early tenders for $1.45 billion notes, to buy all
|
| 3/16/2018 | HY | Market Commentary: Tullow, Husky lead busy primary; Mattel trades on Toys shutdown; Teva still trades under par
|
| 3/16/2018 | HY | Market Commentary: Morning Commentary: Prestige Brands brings $200 million tap to busy primary; Live Nation notes rise
|
| 3/15/2018 | HY | Market Commentary: Live Nation, Aker price new deals; new Guitar Center active; funds gain $11 million
|
| 3/14/2018 | HY | Market Commentary: Guitar Center, NVA bring new deals; newer U.S. Steel, J.C. Penney dominate secondary; Valeant busy
|
| 3/13/2018 | HY | Market Commentary: U.S. Steel prices $650 million; new Valeant dominates secondary; recent Frontier issue adds to volume
|
| 3/12/2018 | HY | Market Commentary: Valeant, American Axle price; Frontier, J.C. Penney new issues continue activity; recent Sprint dominant
|
| 3/12/2018 | CAHYLM | Valeant, unit up tender for 6 3/8%, 5 3/8%, 6¾% notes to $1.5 billion
|
| 3/12/2018 | CAHY | New Issue: Valeant prices upsized $1.5 billion 9¼% eight-year notes at par
|
| 3/12/2018 | BKCAHY | Fitch gives B-/RR4 to Valeant notes
|
| 3/12/2018 | BKCAHY | Moody’s rates Valeant notes Caa1
|
| 3/12/2018 | CAHY | Valeant to sell $1.25 billion eight-year notes in Monday drive-by; whisper is 9¼%-9½% area
|
| 3/12/2018 | CAHYLM | Valeant, unit tender for $1.25 billion of 6 3/8%, 5 3/8%, 6¾% notes
|
| 3/6/2018 | BKCAHY | Fitch rates Valeant, facility, notes
|
| 2/28/2018 | HY | Market Commentary: Warner Music, Kennedy-Wilson add-on price; Sprint continues to dominate secondary; Frontier active
|
| 2/28/2018 | BKBWCAHY | Valeant cuts debt to $25.5 billion; further debt cuts planned in 2018
|
| 2/28/2018 | CAHYLM | Valeant Pharmaceuticals calls $71 million 7% senior notes due 2020
|
| 1/5/2018 | HY | Market Commentary: Primary quiet as junk closes year’s first week, pick up expected; oil names ease
|
| 1/5/2018 | HY | Market Commentary: Energy names mixed as oil prices ease; coal operator Murray continues gains; Sprint busy
|
| 1/4/2018 | HY | Market Commentary: Storm stills junk but energy rise rolls on; Rite Aid recovers; funds gain $186 million
|
| 1/4/2018 | HY | Market Commentary: Distressed debt quiet amid major winter storm; energy stays strong, retailing names gain
|
| 1/3/2018 | HY | Market Commentary: Junk market again firm, led by energy surge; Rite Aid off after results; Hovnanian gyrates amid re-fi news
|
| 1/2/2018 | HY | Market Commentary: Junk primary quiet as 2018 opens; CalRes surges on crude price rise, Chesapeake up as gas prices gain
|
| 12/29/2017 | HY | Market Commentary: Outlook 2018: High-yield primary expected to generate $270-$350 billion of issuance in year ahead
|
| 12/22/2017 | HY | Market Commentary: Junk quiet in pre-holiday session; Medical Properties Trust off, Valeant up; Kindred ends week up
|
| 12/22/2017 | HY | Market Commentary: Pre-holiday distressed market trading quiet; recent Valeant up; Cobalt convertibles gyrate
|
| 12/21/2017 | HY | Market Commentary: Primary quiet as holiday nears; CalRes, Valeant, new Mattel up, funds plunge $1.11 billion
|
| 12/21/2017 | HY | Market Commentary: Distressed trading quiet ahead of holiday; Cal Res, Valeant active, Cobalt converts shed points
|
| 12/18/2017 | HY | Market Commentary: Fortress prices upsized add-on, Lonestar ahead; new Mattel busy; Kindred jumps on Humana talks
|
| 12/18/2017 | HY | Market Commentary: PetSmart paper, existing Mattel notes rebound; Valeant gains, Fresh Market falters
|
| 12/15/2017 | HYLM | Valeant gives early tender results, increases subcap for 5 3/8% notes
|
| 12/15/2017 | HY | Market Commentary: American Midstream, SunCoke drive by; PetSmart pounded again; funds lose $922 million
|
| 12/14/2017 | HY | Market Commentary: PetSmart, Mattel fall again; MEG Energy off on legal claim; new, existing Valeant paper eases
|
| 12/13/2017 | HY | Market Commentary: Morning Commentary: Tidewater launches C$100 million notes; new Whiting Petroleum bonds trade up
|
| 12/12/2017 | HY | Market Commentary: Upsized Whiting megadeal, Iron Mountain lead $2.63 billion day; new Whiting jumps; more PetSmart punishment
|
| 12/11/2017 | HY | Market Commentary: PetSmart pummeled on Chewy spinoff fears; CenturyLink climbs as deal boosts shares
|
| 12/11/2017 | HY | Market Commentary: NFP prices add-on; Standard does a split-rate; recent Valeant again firms; Algeco up on financing news
|
| 12/8/2017 | HY | Market Commentary: ACE Cash, Itron, revamped BMC close $11.2 billion primary week; new Jeld-Wen busy
|
| 12/8/2017 | HY | Market Commentary: Energy deals move up along with crude; Valeant paper pops; Community Health notes rebound
|
| 12/7/2017 | HY | Market Commentary: Primary surge resumes, Jeld-Wen, Vantiv lead; new Mercer up more; funds add $217 million
|
| 12/6/2017 | HY | Market Commentary: New Valeant bonds again busy, Claire’s climbs on results; Tronox tumbles; oil names slide
|
| 12/6/2017 | HY | Market Commentary: Primary pace slackens as Mercer brings sole dollar deal; recent issues lead actives list; Claire’s climbs on results
|
| 12/5/2017 | HY | Market Commentary: Quicken megadeal paces second straight $3.5 billion day; heavy trading in new Valeant, older bonds busy too
|
| 12/5/2017 | HY | Market Commentary: New, existing Valeant bonds busy, better; Cal Res, other oils higher; Intelsat bonds drop
|
| 12/5/2017 | HY | Market Commentary: Upsized Valeant, Continental Resources megadeals lead $3.5 billion session; energy surges despite crude fall
|
| 12/5/2017 | HY | Market Commentary: Upsized Valeant, Continental Resources megadeals lead $3.5 billion session; energy surges despite crude fall
|
| 12/4/2017 | HY | Market Commentary: Energy gains despite crude oil slide; retailers on the rise; communications credits mixed
|
| 12/4/2017 | CAHYLM | Valeant offers to buy back up to $1.5 billion 7%, 6 3/8%, 5 3/8% notes
|
| 12/4/2017 | BKCAHY | S&P rates Valeant Pharmaceuticals notes B-
|
| 12/4/2017 | BKCADDHY | Moody’s gives Valeant notes Caa1
|
| 12/4/2017 | CAHY | New Issue: Valeant sells upsized $1.5 billion 9% senior notes due 2025 at 98.611 to yield 9¼%
|
| 12/4/2017 | CAHY | Valeant to price $1 billion eight-year notes in Monday drive-by
|
| 12/4/2017 | CAHYLM | Valeant, unit begin month-long tender for $1 billion of three issues
|
| 11/17/2017 | HY | Market Commentary: Hess, Match, Five Point, Welltec cap $8.36 billion week; energy rise continues
|
| 11/16/2017 | HY | Market Commentary: MultiPlan leads $2 billion primary, market firms broadly; funds plunge $4.4 billion
|
| 11/15/2017 | HY | Market Commentary: Centennial is lone pricing as primary calms; some Tuesday deals busy; Murray slides as Bowie buyout dies
|
| 11/15/2017 | CLHY | Market Commentary: Advanced Disposal, Valeant, Entercom, National Vision, Outfront, Playa and more break
|
| 11/15/2017 | HY | Market Commentary: Morning Commentary: Junk slips ¼ to ½ point, Verisure talks €1.15 billion two-part bond offering
|
| 11/14/2017 | HY | Market Commentary: Lennar megadeal, Valeant add-on pace $3.8 billion primary day; energy names off on crude oil plunge
|
| 11/14/2017 | HY | Market Commentary: Lennar megadeal, Valeant add-on pace $3.8 billion primary day; energy names off on crude oil plunge
|
| 11/14/2017 | CAHY | New Issue: Valeant Pharmaceuticals sells $750 million tap of 5½% secured notes due 2025 at par
|
| 11/14/2017 | CAHY | Valeant Pharmaceuticals talks $750 million tap of 5½% notes at par; pricing Tuesday
|
| 11/13/2017 | HY | Market Commentary: Resolute deal on, then off; Valeant shops add-on; Rite Aid firms; market weakens as daily outflows swell
|
| 11/13/2017 | HY | Market Commentary: Resolute deal on, then off; Valeant shops add-on; Rite Aid firms; market weakens as daily outflows swell
|
| 11/13/2017 | CAHY | Valeant to price $750 million tap of 5½% secured notes due 2025; pricing expected Tuesday
|
| 11/10/2017 | HY | Market Commentary: Platform, Precision, Titan price, trade actively; market weak again; funds out $622 million
|
| 11/9/2017 | HY | Market Commentary: Cenveo slides on poor earnings; energy names weak, Level 3 loses; other telecoms see a bounce
|
| 11/9/2017 | CLHY | Market Commentary: First Data, Seahawk, Burlington, Utility One break; Avaya, Intralinks, Chassix set changes
|
| 11/8/2017 | BKCADDHY | Moody’s revises Valeant to stable
|
| 11/7/2017 | HY | Market Commentary: Primary quiets down, though Michael Baker slates deal; new QEP steady; Windstream falls; oils, Valeant jump
|
| 11/7/2017 | HY | Market Commentary: Energy names, Valeant gain – but Mallinckrodt, Community Health and Sprint get hammered
|
| 11/7/2017 | BKBWHY | Valeant touts progress on debt cutting, reaches $5 billion pay-down target sooner than expected
|
| 11/7/2017 | HY | Market Commentary: Morning Commentary: Valeant, California Resources outperform flat junk market; Michael Baker eyed
|
| 10/24/2017 | HY | Market Commentary: Wind Tre prices $2 billion dollar deal as part of giant transaction; new notes trade up; Netflix, GSL busy
|
| 10/16/2017 | HY | Market Commentary: Pattonair prices; new Friday names busy; Ruby Tuesday jumps on buyout; hospitals steady after Friday drop
|
| 10/16/2017 | CAHYLM | Valeant tenders for $1 billion notes oversubscribed at early deadline
|
| 10/3/2017 | HY | Market Commentary: Downsized West, upsized Energy Transfer, PBF add-on price; existing Valeants fall; Intelsat improves
|
| 10/3/2017 | HY | Market Commentary: Crown Rock, Valeant, Scientific Games drive by; Crown Rock, Games gain; new Caesars notes busy, Murray up
|
| 10/2/2017 | CAHY | New Issue: Valeant sells $1 billion eight-year secured notes at par to yield 5½%
|
| 10/2/2017 | BKCAHY | S&P rates Valeant notes BB-
|
| 10/2/2017 | BKCAHY | Moody’s gives Valeant notes Ba3
|
| 10/2/2017 | CAHY | Valeant to price $1 billion eight-year secured notes on Monday backing tender offer
|
| 10/2/2017 | CAHYLM | Valeant Pharmaceuticals tenders for $1 billion of three note series
|
| 9/29/2017 | HY | Market Commentary: Caesars prices $1.7 billion, gains in trading; Jonah stays firm; Valeant up on asset sale
|
| 9/25/2017 | BKBWCVDDHY | Valeant may lower ‘hefty’ debt through equity-linked securities sale
|
| 8/25/2017 | HY | Market Commentary: Morning Commentary: Late summer liquidity continues to thin; junk funds see mixed Thursday flows
|
| 8/11/2017 | HY | Market Commentary: Concordia firms post-earnings; Hexion results weigh on debt; Petsmart gets a bounce
|
| 8/10/2017 | HY | Market Commentary: Petsmart paper drops on CEO exit; Navios down; Valeant, California Resources remain active
|
| 8/9/2017 | HY | Market Commentary: TMS Int’l, David Weekley, Clear Channel Outdoor price; Hertz heads higher, Valeant gives up gains
|
| 8/9/2017 | HY | Market Commentary: Hertz rebounds as company touts plan; Cobalt eyed post-earnings; Valeant gives back
|
| 8/8/2017 | HY | Market Commentary: Upsized Restaurant Brands megadeal, Triumph and WPX price; new Dynegy paper busy; Valeant jumps
|
| 8/8/2017 | CLHY | Market Commentary: TransDigm dips with new loan launch; Valeant rises; United Site, Constellis set changes
|
| 8/8/2017 | HY | Market Commentary: Valeant results beat, bonds firm; Endo earnings better; Depomed convertibles tank
|
| 8/8/2017 | BKBWDDHY | Valeant says will achieve $5 billion debt-reduction goal ahead of scheduled February 2018 target
|
| 8/8/2017 | HY | Market Commentary: Morning Commentary: New issue market active; health care names in spotlight; Valeant up 2 points
|
| 8/7/2017 | HY | Market Commentary: Mallinckrodt dips on InfaCare purchase; Endo, Valeant earnings on tap; Fannie Mae up
|
| 7/26/2017 | HY | Market Commentary: Ashton Woods prices, firms; new NGPL tranches jump on big volume; energy upturn continues
|
| 7/17/2017 | HY | Market Commentary: Lithia prices, rises; new Hovnanians continue climb; Valeant firms on asset-sale news
|
| 7/17/2017 | HY | Market Commentary: iHeart up on restructuring news; Valeant perks on asset sale; Endo, Frontier busy, better
|
| 7/13/2017 | HY | Market Commentary: Frontier stays busy, ends lower; Intelsat gains amid hopeful merger buzz; Valeant better
|
| 7/13/2017 | CAHYLM | Valeant to call $500 million of 6¾% notes due 2018 on Thursday
|
| 7/6/2017 | HY | Market Commentary: Oil pares session gains; E&P lower; Energy Future surges on takeover talks; Valeant down
|
| 6/29/2017 | HY | Market Commentary: Rite Aid gains after Walgreens opts for assets; energy rises as oil gains; Valeant lower
|
| 6/28/2017 | HY | Market Commentary: California Resources, EP Energy gain as oil goes higher; Valeant ticks up; Hertz quiets
|
| 6/26/2017 | HY | Market Commentary: Hertz up on rumors of potential Apple partnership; Rite Aid rises on FTC buzz; E&P higher
|
| 6/23/2017 | HY | Market Commentary: California Resources sees ‘tons of trades,’ but unmoved as oil gains; Jones Energy down
|
| 6/22/2017 | HY | Market Commentary: J2 prices; Senate bill drives health higher; Rite Aid lower on report; funds out $128 million
|
| 6/22/2017 | HY | Market Commentary: Valeant, Community Health higher; E&P up with oil gains; PetSmart continues slide
|
| 6/20/2017 | HY | Market Commentary: Existing Intelsat issues down; E&P falls as oil enters bear market; Valeant changes course
|
| 6/19/2017 | HY | Market Commentary: Intelsat Jackson higher on $1.5 billion new notes; Valeant up after Paulson brought on
|
| 6/15/2017 | HY | Market Commentary: California Resources again most active in faltering E&P space; Valeant down across board
|
| 6/14/2017 | HY | Market Commentary: California Resources leads E&P losses as oil tanks; Intelsat higher; Endo trends lower
|
| 6/9/2017 | HY | Market Commentary: Navient prices add-on to cap nearly $6 billion week; new HCA firms in busy trading; Rite Aid slide continues
|
| 6/9/2017 | HY | Market Commentary: Valeant asset-sale gains go on; Bristow jumps on realignment; Rite Aid slide continues
|
| 6/9/2017 | BWCAHY | Valeant seeks to cut, but not eliminate, debt from capital structure
|
| 6/8/2017 | HY | Market Commentary: HCA split-rated deal prices; recent issues mostly easier; Valeant up on asset sale; funds gain $586 million
|
| 6/8/2017 | HY | Market Commentary: Valeant bonds up on asset sale; most oil issues firmer; Intelsat gains altitude
|
| 6/7/2017 | BKBWHY | Valeant CEO says debt paydown gives company ‘runway’ for turnaround
|
| 6/6/2017 | HY | Market Commentary: California Resources lower amid oil rise; Valeant unchanged; Walter Investment higher
|
| 6/5/2017 | HY | Market Commentary: Mallinckrodt down; Walter Investment up on debt adviser news; California Resources drift
|
| 6/2/2017 | HY | Market Commentary: Intelsat gains back losses after exchange offer falls apart; Hertz mixed; E&P names down
|
| 5/18/2017 | HY | Market Commentary: Intelsat amends exchange offer, bonds rise; Valeant up; E&P mixed on low-volume session
|
| 5/16/2017 | HY | Market Commentary: Noble Group continues to leak; Intelsat extends offer, off a little; GenOn Energy mixed
|
| 5/11/2017 | HY | Market Commentary: Valeant mixed, less busy; Cengage down on earnings, Talen up; Intelsat mixed on extension
|
| 5/10/2017 | HY | Market Commentary: Frontier leads with slight gain; Valeant ‘wildly active’; Intelsat improves; Concordia up
|
| 5/9/2017 | HY | Market Commentary: Valeant sees big gains after debt reduction; Hertz down on earnings miss; Intelsat lower
|
| 5/8/2017 | HY | Market Commentary: California Resources most active for second session; GenOn, Talen higher; Neiman unchanged
|
| 5/5/2017 | HY | Market Commentary: Post earnings, California Resources up; GenOn ‘not as active,’ but up; Revlon, Neiman down
|
| 5/3/2017 | HY | Market Commentary: Earnings-related activity moves Community Health, Fresh Market, CF Industries
|
| 5/2/2017 | HY | Market Commentary: Community Health jumps on quarterly results; Valeant follows; California Resources drops
|
| 5/1/2017 | HY | Market Commentary: USG, New Home drive by; Covey Park most active; Pharmaceutical Product nearly unchanged; Petsmart higher
|
| 5/1/2017 | HY | Market Commentary: Petsmart higher after Friday drop; Community Health, Valeant unresponsive to good news
|
| 4/27/2017 | HY | Market Commentary: Intelsat, Ensco mostly undisturbed by earnings releases; iHeart down as exchange extended
|
| 4/26/2017 | HY | Market Commentary: California Resources higher with oil; Intelsat up ahead of earnings; iHeart ticks lower
|
| 4/24/2017 | HY | Market Commentary: Community Health ticks higher on low-volume session; iHeart inactive; Intelsat gains
|
| 4/21/2017 | HY | Market Commentary: Ocwen rebounds after plunge; California Resources continues to tick down; Valeant falls
|
| 4/20/2017 | HY | Market Commentary: Ocwen Financial down big after lawsuit comes forward; Petsmart down; pharma mixed
|
| 4/19/2017 | HY | Market Commentary: Oil drops sharply, as do California Resources, Pacific Drilling; Petsmart also down
|
| 4/18/2017 | HY | Market Commentary: Cumberland prices; Petsmart surges on Chewy acquisition; Post up a bit after buying Weetabix; pharma down
|
| 4/18/2017 | HY | Market Commentary: Petsmart sees intraday swing post-acquisition; Avaya calms after Monday rise; pharma drops
|
| 4/12/2017 | HY | Market Commentary: SNF Floerger, Tutor Perini, Endo, Tennant price; Toys ‘R’ Us jumps; recent Barminco, Ultra mixed; Endo rebounds
|
| 4/12/2017 | HY | Market Commentary: Toys ‘R’ Us up several points after Q4 results; Endo International rebounds; Valeant down
|
| 4/10/2017 | HY | Market Commentary: New Cedar Fair, recent Ultra Petroleum, Alliance take attention on session; oil, health care, retail trade tight
|
| 4/6/2017 | HY | Market Commentary: Oil companies rule market as crude advances; Accudyne higher; iHeart eyed on tender news
|
| 4/5/2017 | HY | Market Commentary: Energy names firm as oil prices continue gains; Hertz brakes slide seen on Tuesday
|
| 4/3/2017 | HY | Market Commentary: Energy Future pares losses; Community Health sees small dip; Hertz down with auto industry
|
| 3/31/2017 | HY | Market Commentary: Energy Future ‘volatile’ after acquisition falls through; California Resources nearly flat
|
| 3/30/2017 | HY | Market Commentary: Talen trades up as tender, term loan announced; E&P’s up on oil; Valeant, Concordia gain
|
| 3/30/2017 | BKCADDHY | Moody’s ups Valeant to SGL-2
|
| 3/29/2017 | HY | Market Commentary: Oil and related E&P higher for second session; Quorum Health down sharply; Valeant rises
|
| 3/27/2017 | HY | Market Commentary: Community Health up as health care bill loss sinks in; Valeant down; energy mixed
|
| 3/24/2017 | HY | Market Commentary: Euro deals price, but dollar market quiet to close $3.65 billion week; Dole, secured BWAY firm
|
| 3/24/2017 | HY | Market Commentary: Community Health ‘wildly active’; Valeant up across the board; retailers drop
|
| 3/23/2017 | HY | Market Commentary: Community Health up marginally as health bill stalls; Concordia, Avaya dip; iHeart quiet
|
| 3/22/2017 | HY | Market Commentary: Retail, including Bon-Ton, J.C. Penney, mixed after J. Crew results; Valeant up; oil down
|
| 3/21/2017 | HY | Market Commentary: Valeant trades down on overall lower session; Petsmart follows; recent issues First Quantum, AK Steel down
|
| 3/21/2017 | HY | Market Commentary: Valeant bleeding continues on down session; Community Health loses amid healthcare debate; Intelsat lower
|
| 3/21/2017 | CAHYLM | Valeant accepts 70.9% of tendered 6¾% notes in oversubscribed offer
|
| 3/20/2017 | HY | Market Commentary: iHeart up after several downtrodden sessions; Valeant, Concordia slip again; Neiman flat
|
| 3/17/2017 | HY | Market Commentary: iHeart continues slide, Valeant, Concordia continue struggles; Walter rebounds, Exco up
|
| 3/16/2017 | HY | Market Commentary: Guitar Center, Walter down following results; Concordia, iHeart fall; Neiman stagnant
|
| 3/15/2017 | HY | Market Commentary: Eldorado prices, firms, while Foresight and Quantum deals on tap; market firms after Fed rate move
|
| 3/15/2017 | HY | Market Commentary: After results, Concordia sees big losses; Valeant rebounds after ‘whipsaw’ week; Neiman up
|
| 3/14/2017 | HY | Market Commentary: Primaryside focus turned to Europe; new T-Mobile, AMC deals active; new Valeant joins retreat
|
| 3/14/2017 | HY | Market Commentary: Valeant lower as Ackman exits shares; Neiman Marcus gains; energy slide continues
|
| 3/14/2017 | CLHY | Market Commentary: Valeant, Arctic Glacier, Camping World, Navico free to trade; Horizon Pharma terms surface
|
| 3/14/2017 | HY | Market Commentary: T-Mobile three-part megadeal, AMC drive by, new AMC gains; new Valeant again firm, existing paper off
|
| 3/13/2017 | HY | Market Commentary: Valeant existing bonds slide more, new paper up; energy still weak but drillers rebounding
|
| 3/10/2017 | HY | Market Commentary: New Valeant bonds jump, existing issues continue retreat; Intelsat gains; energy still weak
|
| 3/10/2017 | HY | Market Commentary: New Home, Fortress price to cap $17.54 billion week, biggest of all time, recent deals busy
|
| 3/10/2017 | CAHYLM | Valeant lifts tender offer cap for 6¾% notes due 2018 to $1.1 billion
|
| 3/9/2017 | HY | Market Commentary: Valeant, American Axle, Charter lead year’s biggest day so far; funds plunge $2.12 billion
|
| 3/9/2017 | CAHY | New Issue: Valeant prices upsized to $3.25 billion secured notes in two tranches
|
| 3/9/2017 | CLHY | Market Commentary: Avantor, Hilton, Boyd, Caraustar, SRAM break; Aramark, HCA, Allnex, Valeant update deals
|
| 3/9/2017 | HY | Market Commentary: Oil slips again, but distressed doesn’t ‘capitulate’ as much; existing Valeant up
|
| 3/9/2017 | BKCAHY | S&P provides BB- to Valeant notes
|
| 3/9/2017 | CAHY | Valeant to sell $2.5 billion secured notes in two parts on Thursday
|
| 3/8/2017 | HY | Market Commentary: Plummeting oil brings California Resources, others down; Community Health, Valeant down
|
| 3/7/2017 | HY | Market Commentary: Community Health, Hilton Worldwide megadeals lead $4.7 billion session, year’s busiest; healthcare names sink
|
| 3/7/2017 | CAHYLM | Valeant begins tender offer for up to $600 million 6¾% notes due 2018
|
| 3/6/2017 | HY | Market Commentary: Aircastle and Olin drive-by issues plus Vermilion price; calendar swells; new Blue Line, CyrusOne busy
|
| 3/6/2017 | CLHY | Market Commentary: Navios, Atrium Innovations, Aspen Dental break; Valeant term F dips; Allnex makes changes
|
| 3/6/2017 | HY | Market Commentary: Valeant up across board post-refinancing news; Community Health up; Neiman, Intelsat down
|
| 3/6/2017 | BKCAHY | Moody’s rates Valeant facilities, notes Ba3
|
| 3/6/2017 | CAHY | Valeant plans new debt securities as part of debt refinancing
|
| 3/3/2017 | HY | Market Commentary: Intelsat wraps up week on decline; Neiman down after Lazard hire; Valeant mixed post-sale
|
| 3/2/2017 | HY | Market Commentary: Intelsat mixed and most active; Valeant continues rebound; iHeart up across the board
|
| 3/1/2017 | HY | Market Commentary: Dollar pricings again absent, but Blue Line, Vermilion slate; Avis prices euro deal; Intelsat gains go on
|
| 3/1/2017 | HY | Market Commentary: Intelsat posts third session of gains; Valeant ‘marginally’ better; Neiman rally rolls on
|
| 2/28/2017 | HY | Market Commentary: Dollar primary still on hold, Stonegate to shop sterling deal; Intelsat adds to gains, Valeant off on results
|
| 2/28/2017 | HY | Market Commentary: Intelsat gains after confirming merger; Valeant down post-results; Endo, Neiman unchanged
|
| 2/27/2017 | HY | Market Commentary: Intelsat up big on reported merger talks with OneWeb; Valeant up marginally before results
|
| 2/24/2017 | HY | Market Commentary: Community Health ‘lackluster;’ retailers mixed after J.C. Penney announces store closings
|
| 2/21/2017 | HY | Market Commentary: Community Health explodes; Quorum Health follows; pharma mixed, Valeant, Intelsat up
|
| 2/16/2017 | HY | Market Commentary: Hornbeck Offshore down big post-Q4 results; Murray rises more; Valeant, Avaya, Hertz down
|
| 2/6/2017 | HY | Market Commentary: Community Health active; Vanguard Natural continues losses after Chapter 11; Neiman down
|
| 2/3/2017 | HY | Market Commentary: Bankruptcy news sets in for Vanguard Natural; Algeco up on exchange; Neiman trades tightly
|
| 2/1/2017 | HY | Market Commentary: Under Armour drops into distressed territory; Community Health gains; pharma goes up
|
| 1/31/2017 | HY | Market Commentary: Intelsat sees softer gains; Community Health rises; pharmaceuticals down; Peabody up
|
| 1/30/2017 | HY | Market Commentary: Intelsat gains for third session; Neiman down a ‘smidge’; Peabody pares loss; E&P mixed
|
| 1/25/2017 | HY | Market Commentary: Avaya sees big spike, some mixture; Neiman Marcus gains go on; Valeant rumors spur upticks
|
| 1/24/2017 | HY | Market Commentary: Avaya up on DIP financing; Neiman Marcus recoups Monday loss; E&P steady; pharma mixed
|
| 1/23/2017 | HY | Market Commentary: United Continental, Baffinland and Century Communities price in quieter session; TransDigm, Rite Aid busy
|
| 1/23/2017 | HY | Market Commentary: Bleeding goes on for Neiman Marcus, declines steep; Avaya up; healthcare, pharma mixed
|
| 1/20/2017 | CLHY | Market Commentary: TransDigm hit on short-seller report; Cengage, McGraw-Hill loans tumble, Inflows continue
|
| 1/12/2017 | HY | Market Commentary: Valeant ‘top dog’ on most active list; Community Health swings down; Murray active; Avaya dips
|
| 1/11/2017 | HY | Market Commentary: Novalex prices; Team Health ahead; Valeant down on post-asset sale, Trump comments; E&P mixed
|
| 1/11/2017 | HY | Market Commentary: Valeant down on post-asset sale, Trump; Murray Energy up; iHeart stays active pre-auction
|
| 1/10/2017 | HY | Market Commentary: No pricings, but Novolex on tap, Icahn on the road; Sabine Pass up on ratings boost, Valeant on asset sale
|
| 1/10/2017 | CLHY | Market Commentary: Ascena dips with sales results; Valeant up on asset sale plans; Synchronoss revises deadline
|
| 1/10/2017 | HY | Market Commentary: Valeant Pharmaceuticals up big on two asset sales; Avaya continues fall; Neiman Marcus up
|
| 1/10/2017 | HY | Market Commentary: Morning Commentary: Icahn brings $900 million two-part deal; Valeant up on asset sale news
|
| 1/9/2017 | HY | Market Commentary: Intelsat, Avaya down on calm day; Valeant, Community Health quieter; E&P mixed as oil dips
|
| 1/6/2017 | HY | Market Commentary: Community Health closes week on high note; Neiman Marcus unchanged; E&P nearly flat
|
| 1/5/2017 | HY | Market Commentary: Hospitals continue gains from Obamacare dismantling talk; retailers see bad holiday sales
|
| 1/4/2017 | HY | Market Commentary: Community Health, Quorum among gainers on Obamacare shedding; Bonanza surges on Chapter 11
|
| 12/21/2016 | HY | Market Commentary: iHeart steals action with ruling, moving notes both ways; Peabody down; Valeant mixed
|
| 12/20/2016 | HY | Market Commentary: Volume stays low in pre-holiday calm; Valeant down; iHeart mixed; one-off names trade
|
| 12/19/2016 | HY | Market Commentary: Valeant most active in quiet distressed land; idiosyncratic names move in both directions
|
| 12/16/2016 | HY | Market Commentary: Distressed markets slow; iHeartMedia down several points; energy mixed on oil future rise
|
| 12/15/2016 | HY | Market Commentary: Distressed market quiet overall, but Valeant swings; Peabody continues slide; energy down
|
| 12/13/2016 | HY | Market Commentary: Upsized AmeriGas, Concho, American Midstream price; recent RSP Permian, Carlson issues trade up
|
| 12/13/2016 | HY | Market Commentary: Peabody loses ahead of restructuring; iHeart up on intraday swings; Neiman Marcus down
|
| 12/2/2016 | HY | Market Commentary: Intelsat bonds bounce around on filing disclosures; energy issues keep firming; Valeant rebounds
|
| 12/1/2016 | HY | Market Commentary: Oil sector extends gains following OPEC accord; Memorial Production up after forbearance
|
| 11/30/2016 | CLHY | Market Commentary: Zayo, Electric Lightwave react to acquisition news; Valeant weakens; Save-A-Lot tweaks deal
|
| 11/30/2016 | HY | Market Commentary: OPEC accord lifts oil sector, California Resources; Valeant Pharma down on asset sale bust
|
| 11/23/2016 | HY | Market Commentary: Firmer junk market quietly heads into holiday break; new Conduent paper well above issue price
|
| 11/22/2016 | HY | Market Commentary: Ultra Petroleum gets huge gain; Peabody rallies on commodity momentum; oil mixed
|
| 11/17/2016 | HY | Market Commentary: Little movement on charges against Valeant execs; Peabody reacts to China’s coal expansion
|
| 11/15/2016 | HY | Market Commentary: Valeant Pharma seeks to decrease debt load; oil up with promising agreement on horizon
|
| 11/15/2016 | BKBWCADDHYLM | Valeant aims to pay $5 billion of $30 billion debt via asset sales
|
| 11/14/2016 | HY | Market Commentary: Hexion up after note buyback discussed; CHC mixed on reorganization; hospitals, pharma dip
|
| 11/9/2016 | HY | Market Commentary: Trump presidency upticks trickle down, some industries drop; pharma up, hospitals decline
|
| 11/8/2016 | HY | Market Commentary: Primary stays quiet, Telesat Canada downsizes, CF deal seen high-grade; Valeant, Hertz dive on numbers
|
| 11/8/2016 | HY | Market Commentary: Valeant Pharmaceuticals takes nosedive on earnings announcement; Concordia continues fall
|
| 11/8/2016 | CLHY | Market Commentary: AssuredPartners, Netsmart, CSRA break; Hertz, Valeant slide with earnings, slashed outlooks
|
| 11/8/2016 | BKCADDHY | Moody’s lowers Valeant, facilities, debt
|
| 11/7/2016 | HY | Market Commentary: Concordia down on earnings; Alliance, Valeant anticipate theirs; oil surge pushes prices
|
| 11/3/2016 | HY | Market Commentary: Downsized ServiceMaster prices, also Associated Materials, Kissner; funds dive by $4 billion-plus
|
| 11/3/2016 | HY | Market Commentary: Dollar primary quiets down; sterling deals price; Telesat slates; Tutor Perini spikes deal
|
| 11/1/2016 | HY | Market Commentary: Valeant Pharma loses, then surges; healthcare down; oil bonds follow OPEC speculation
|
| 10/31/2016 | HY | Market Commentary: Oil sector drops after unsuccessful OPEC supply-cut talks; Valeant down on probe news
|
| 10/28/2016 | HY | Market Commentary: Community Health slows after tumultuous Thursday; other healthcare mixed following suit
|
| 10/25/2016 | HY | Market Commentary: Sprint, T-Mobile see some movement; new Netflix, URI trade; communications ride AT&T takeover talks
|
| 10/18/2016 | HY | Market Commentary: Industrial metals rally; energy names bounce; Sprint debt continues to roll following preliminary results
|
| 10/17/2016 | HY | Market Commentary: High-yield opens week with mixed tone; Supervalu sees strides on Save-A-Lot sale; Sprint builds on momentum
|
| 10/17/2016 | HY | Market Commentary: Peabody gains, oil and gas mixed after production numbers; Intelsat, Valeant bonds falter
|
| 10/13/2016 | HY | Market Commentary: Valeant drops with Q3 announcement on horizon; Nortel up after settlement; Alliance leaks after deal
|
| 10/13/2016 | HY | Market Commentary: Morning Commentary: Junk lower amid weaker equities; Warner Music euro tranche prices tight
|
| 8/18/2016 | BKCAHY | Valeant lenders OK amendment permitting loan paydown with notes
|
| 8/11/2016 | HY | Market Commentary: XPO, Service King drive by, XPO gains; Community Health, Valeant lower; funds add $1.655 billion
|
| 8/11/2016 | CLHY | Market Commentary: XPO, Polyconcept, Continental Building, Headwaters, WaveDivision free to trade; Valeant dips
|
| 8/11/2016 | HY | Market Commentary: Ultra Petroleum jumps post-earnings; Valeant debt in retreat; Quorum Health bonds drop
|
| 8/10/2016 | HY | Market Commentary: No dollar deals price, Murphy Oil slates; new MGM Growth, Builders, Veritas issues active
|
| 8/10/2016 | CLHY | Market Commentary: NEW Asurion, Trader, Truck Hero, Oasis break; Valeant gains; SolarWinds, WaveDision tweaked
|
| 8/10/2016 | BKCAHY | Moody’s: Valeant unchanged by amendment
|
| 8/10/2016 | BKCAHY | Valeant launches amendment to permit loan paydown with senior notes
|
| 8/9/2016 | HY | Market Commentary: Builders First Source leads continued drive-by parade, new bonds pop; Valeant jumps on results, guidance
|
| 8/9/2016 | CLHY | Market Commentary: Leslie’s, WCA Waste break; Walter rises; Valeant better with amendment and asset sale talk
|
| 8/9/2016 | HY | Market Commentary: Leslie’s, WCA Waste break; Walter rises; Valeant better with amendment and asset sale talk
|
| 8/9/2016 | HY | Market Commentary: Valeant better as guidance affirmed; Walter Investments pops on sales; Guitar Center wanes
|
| 8/9/2016 | BKBWCAHYLM | Valeant says debt-cutting remains a focus, $880 million cut since Q1, seeks covenant relief
|
| 7/20/2016 | HY | Market Commentary: Valeant trades active, better; Tronox debt pushes higher; energy space, Intelsat end mixed
|
| 7/13/2016 | HY | Market Commentary: Primary busts loose with $2.73 billion session; new deals trade up; overall market seen easier
|
| 7/13/2016 | HY | Market Commentary: Valeant Pharmaceuticals declines; Intelsat dwindles; little follow-through in Claire’s
|
| 7/8/2016 | HY | Market Commentary: New Transocean notes busy, better; primary quiet but hopeful; overall junk market stronger
|
| 7/8/2016 | HY | Market Commentary: Distressed bonds mostly better along with junk market; energy, Chemours, Valeant up, Intelsat off
|
| 6/10/2016 | BKCAHY | Moody’s ups Valeant liquidity
|
| 6/7/2016 | HY | Market Commentary: Gray TV, Six Flags drive by, Zekelman also prices, new bonds busy, higher; Valeant gyrates at lower levels
|
| 6/7/2016 | HY | Market Commentary: Valeant Pharmaceuticals reports disappointing results, cuts guidance; oil and gas firms
|
| 6/7/2016 | BKBWHYLM | Valeant liquidity ‘solid,’ committed to $1.7 billion debt reduction
|
| 6/3/2016 | CADDHY | Valeant again triggers note defaults for holdup in filing financials
|
| 5/27/2016 | HY | Market Commentary: Primary quiet to end $11 billion week; Yum! slates megadeal; Valeant up on M&A buzz
|
| 5/27/2016 | HY | Market Commentary: Distressed bond trading muted as holiday nears; Valeant bonds improve on takeover news
|
| 5/23/2016 | BKDDHY | Valeant plans to use asset sale proceeds to tackle debt, says new CEO
|
| 5/19/2016 | CADDHY | Valeant Pharmaceuticals gets default notice after delay filing 10-Q
|
| 5/19/2016 | HY | Market Commentary: Halcon Resources’ debt gains on prepackaged news; Valeant bonds drift lower; Caesars also weakens
|
| 5/18/2016 | HY | Market Commentary: Valeant Pharmaceuticals weighs asset sales; Intelsat reduces tender pricing; Caesars busy
|
| 5/13/2016 | HY | Market Commentary: Morning Commentary: Junk bonds off a touch early Friday, but trader still sees better buyers
|
| 5/3/2016 | BKCVHY | Moody’s lifts Valeant probability rating
|
| 5/3/2016 | BKCVHY | S&P: Valeant on positive watch
|
| 4/29/2016 | HY | Market Commentary: Ardagh brings $4.5 billion to strong demand; Western Digital off post-earnings; Valeant pressured
|
| 4/29/2016 | HY | Market Commentary: Valeant pressured as 10-K filed; First Quantum rises on earnings beat; AK Steel bonds slip
|
| 4/27/2016 | HY | Market Commentary: Energy names jump on firmer oil; Gymboree gains; Valeant firms despite Senate scrutiny
|
| 4/27/2016 | HY | Market Commentary: Morning Commentary: Valeant bonds gain as Mr. Ackman goes to Washington; Corral sets talk
|
| 4/25/2016 | CADDHY | Valeant Pharmaceuticals defaults on notes after delay filing 10-K
|
| 4/14/2016 | BKCVHY | S&P downgrades Valeant
|
| 4/13/2016 | BKCADDHY | Moody’s drops Valeant liquidity to SGL-4
|
| 4/12/2016 | DDHY | Valeant 5½% noteholders send default notice in light of 10-K delay
|
| 4/7/2016 | HY | Market Commentary: Upsized Charter drives by, eases; new Numericable again tops actives; funds gain $1.18 billion
|
| 4/7/2016 | CLHY | Market Commentary: MGM Growth, Sedgwick, AssuredPartners free to trade; Valeant better with amendment approval
|
| 4/6/2016 | HY | Market Commentary: Numericable deal leads $8 billion primary, heaviest in a year; Ally, Springleaf, MGM price too
|
| 4/6/2016 | CLHY | Market Commentary: Valeant gains more ground; Atlantic Power, MGM Growth, American Renal update deals
|
| 4/5/2016 | HY | Market Commentary: Downsized Diebold prices; new Sunoco still struggling; WDC busy again; Valeant bonds bounce
|
| 4/5/2016 | HY | Market Commentary: Valeant bonds improve as probe concludes; iHeartMedia maintains; energy space moves lower
|
| 4/5/2016 | CLHY | Market Commentary: Diebold, Alvogen, Blount break; Valeant rises; MGM Growth Properties deal updates surface
|
| 4/5/2016 | HY | Market Commentary: Morning Commentary: Junk weakens overnight; Diebold downsizes, sets talk; Valeant bonds rally
|
| 4/1/2016 | HY | Market Commentary: Energy bonds slide with lower oil; SunEdison remains weak; Valeant, AK Steel better
|
| 3/31/2016 | BKCAHY | Moody’s drops Valeant, debt
|
| 3/30/2016 | CLHY | Market Commentary: Valeant rises with amendment; Western Digital breaks; Blount, DYK Automotive changes surface
|
| 3/28/2016 | CLHY | Market Commentary: Valeant dips in trading as CEO summoned to testify; Precyse, NAPA Management on deck
|
| 3/21/2016 | HY | Market Commentary: Intelsat, Aircastle price upsized drive-by deals, new bonds rise; Valeant bonds busy on board turmoil
|
| 3/18/2016 | HY | Market Commentary: Upsized MDC prices to cap $2.57 billion week, moves up; oil names gain; busy Valeant fades
|
| 3/17/2016 | HY | Market Commentary: Primary turns quiet, though MDC on tap; new Kraton, Cinemark busy; funds gain $1.679 billion
|
| 3/16/2016 | HY | Market Commentary: Cinemark brings add-on; Kraton Polymers relaunches deal; Valeant again active, though mixed
|
| 3/16/2016 | CLHY | Market Commentary: Imagine! Print breaks; Valeant partially rebounds; ON Semiconductor changes surface
|
| 3/16/2016 | BKCAHY | S&P: Valeant on negative watch
|
| 3/16/2016 | BKCAHY | Moody’s lowers Valeant, loans, notes
|
| 3/15/2016 | HY | Market Commentary: Radian prices, new bonds jump, recent deals steady; Valeant dives on default warning, lower guidance
|
| 3/15/2016 | CLHY | Market Commentary: Windstream breaks; Neiman up with earnings; Valeant falls on numbers, guidance changes
|
| 3/15/2016 | BKBWCAHY | Valeant in covenant compliance now but faces reporting breaches; ‘comfortable’ with liquidity
|
| 3/15/2016 | BKCADDHY | Valeant delays 10-K, breaching covenants and opening door to default
|
| 3/15/2016 | HY | Market Commentary: Morning Commentary: Junk market softens after big Monday rally; funds see big inflows
|
| 3/2/2016 | CLHY | Market Commentary: Valeant Pharmaceuticals’ term debt rebound continues; ON Semiconductor loan on deck
|
| 3/1/2016 | HY | Market Commentary: Upsized HCA megadeal drives by, bonds rise; new Solera strong; Valeant rebounds, Intelsat fall persists
|
| 3/1/2016 | CLHY | Market Commentary: Valeant Pharmaceuticals sees some improvement; Solera gains; HCA reworks term loan size
|
| 2/29/2016 | HY | Market Commentary: Restructured Solera deal prices; new Lennar busy; Valeant dives on SEC probe, Intelsat off on downgrade
|
| 2/29/2016 | BKCAHY | Moody’s reviews Valeant
|
| 2/26/2016 | HY | Market Commentary: Morning Commentary: Junk market opens to good tone; investors chasing health care, energy, telecom
|
| 2/23/2016 | HY | Market Commentary: Summit Materials drives by, Solera sets talk; Valeant rebounds but Intelsat slide worsens; Whiting falls
|
| 2/23/2016 | CLHY | Market Commentary: Valeant regains some ground; PetSmart slides with dividend payment; GCA Services rises
|
| 2/23/2016 | BKCAHY | Moody’s changes Valeant to negative
|
| 2/23/2016 | HY | Market Commentary: Morning Commentary: Junk market sags in early Tuesday trading; IntelSat, PetSmart bonds sell off
|
| 2/22/2016 | HY | Market Commentary: Primary stays quiet, awaits Solera talk; new Standard Industries firmer; Intelsat dives on revenue
|
| 1/13/2016 | HY | Market Commentary: Market broadly lower; Oasis, other energy credits hit especially hard; primary quiet
|
| 1/7/2016 | HY | Market Commentary: Microsemi brings year’s first syndicated new deal; market lower, funds lose $809 million
|
| 1/5/2016 | HY | Market Commentary: Junk steadies after opening 2016 with loss; Chesapeake gains, primary calm, but M&A deals expected
|
| 12/31/2015 | HY | Outlook 2016: Junk will try to rebound, but energy, commodities weakness overhangs market
|
| 12/22/2015 | HY | Market Commentary: Junk sees improved market tone, helped by better stocks, oil prices; Valeant up; Denbury down
|
| 12/17/2015 | HY | Market Commentary: Two-day junk rally ends; oils lower; Valeant mixed, Navistar up; funds plunge $3.81 billion
|
| 12/16/2015 | HY | Market Commentary: Junk rally continues as Fed hikes rates, primary market remains quiet; Valeant extends gains
|
| 12/16/2015 | BKCAHY | Valeant updates on guidance, aims to chop leverage to 4.0 times area
|
| 12/15/2015 | HY | Market Commentary: Primary quiet; junk turns broadly higher as Fed meets; Valeant jumps on Walgreens arrangement
|
| 12/15/2015 | CLHY | Market Commentary: Valeant rises with Walgreens agreement; Konecranes Terex frees up; MB Aerospace updated
|
| 12/15/2015 | HY | Market Commentary: Morning Commentary: High yield catches a bid amid big demand from ETFs; Valeant bonds up 5 points
|
| 11/10/2015 | HY | Market Commentary: Teekay, ContourGlobal bring add-ons in quiet pre-holiday session; Valeant firms after call
|
| 11/10/2015 | BKBWHY | Valeant says debt reduction a key priority, will use ‘lion’s share’ of cash flow to de-lever
|
| 11/10/2015 | HY | Market Commentary: Morning Commentary: Mallinckrodt bonds bounce off lows; ContourGlobal, Teekay notes on deck
|
| 11/9/2015 | HY | Market Commentary: HCA megadeal drives by, trades actively, Team Health, Contour Global slate; market moves lower
|
| 11/3/2015 | HY | Market Commentary: CNH, upsized Platform Specialty deals price; Platform pops; new T-Mobile jumps on heavy volume
|
| 11/2/2015 | HY | Market Commentary: Goodyear, T-Mobile lead $4.35 billion drive-by parade; Ally and Huntington Ingalls also price
|
| 10/31/2015 | HY | Market Commentary: Primary quiet to close out $6 billion week, $9.4 billion month; Thursday deals rise in heavy trading
|
| 10/30/2015 | CLHY | Market Commentary: First Eagle Investment breaks; Valeant term loans slide; T-Mobile accelerates deadline
|
| 10/30/2015 | HY | S&P downgrades Valeant, debt
|
| 10/30/2015 | HY | Market Commentary: Valeant mixed as Philidor cast aside; latest earnings weighing on Murray, Consol, Intelsat
|
| 10/30/2015 | HY | Market Commentary: Morning Commentary: New First Data, Lennar bonds firm; Valeant jumps on Philidor exit
|
| 10/30/2015 | HY | Market Commentary: First Data megadeal, Level 3 price; Bombardier falls despite aid; funds gain $2.04 billion
|
| 10/28/2015 | HY | Market Commentary: Junk primary quiet, but new L Brands bonds jump; Bombardier flies on government aid report
|
| 10/27/2015 | HY | Market Commentary: L Brands, Toll drive by, new bonds rise; Rite Aid jumps on Walgreens news; Valeant turns mixed
|
| 10/27/2015 | BKCAHY | S&P revises Valeant to negative
|
| 10/27/2015 | HY | Market Commentary: Junk opens flat on Tuesday; Toll Brothers, L Brands on deck; funds see big inflows Monday
|
| 10/26/2015 | HY | Market Commentary: Valeant bonds fall despite company’s presentation; Chesapeake chopped on gas price weakness
|
| 10/26/2015 | CLHY | Market Commentary: Panda Hummel frees up; Valeant softens; handful of companies ready launches for this week
|
| 10/26/2015 | BKCAHY | Valeant forms ad hoc committee to address Philidor concerns, CEO blasts ‘false’ report
|
| 10/26/2015 | HY | Market Commentary: Valeant call fails to improve bonds; new Jarden notes hold premium in quiet Monday trading
|
| 10/24/2015 | HY | Market Commentary: Valeant leads pharma, hospitals rebound; Asbury Auto add-on closes $1.65 billion primary week
|
| 10/23/2015 | HY | Market Commentary: Valeant leads pharma rebound; Platform Specialty off as CEO plans exit; energy names slide
|
| 10/23/2015 | HY | Market Commentary: Hospital names fall on Community Health earnings warning; junk funds see $3.34 billion inflow
|
| 10/22/2015 | HY | Market Commentary: Valeant, other drug makers continue slide; hospital names trade off; energy credits lower
|
| 10/21/2015 | HY | Market Commentary: Valeant bonds crushed as short-seller’s report alleges fraud; Jarden prices; Globo postpones
|
| 10/21/2015 | HY | Market Commentary: Valeant clobbered as report alleges fraud; other pharmaceuticals fall; oil credits lower
|
| 10/21/2015 | CLHY | Market Commentary: Valeant Pharmaceuticals volatile on accusatory research report; Affordable Care revised
|
| 10/20/2015 | HY | Market Commentary: Greatbatch, Concordia price, new bonds diverge; recent Frontier, Cablevision deals busily firmer
|
| 10/20/2015 | HY | Market Commentary: Valeant bonds shed Monday gains; Horizon Pharma converts slide; AMD firm despite downgrade
|
| 10/20/2015 | BKCAHY | Moody’s changes Valeant view to stable
|
| 10/19/2015 | HY | Market Commentary: Primary quiet, though American Energy – Permian on tap; new AerCap keeps firming in active trading
|
| 10/19/2015 | HY | Market Commentary: Valeant bonds firmer after earnings though loans retreat; oils steady despite crude slide
|
| 10/19/2015 | CLHY | Market Commentary: Sucampo breaks; Valeant dips on numbers; Electronic Funds rises; Weight Watchers skyrockets
|
| 10/17/2015 | HY | Market Commentary: AerCap parachutes in with upsized $1 billion deal, new bonds fly; Valeant, oils, Wynn all rebound
|
| 10/16/2015 | HY | Market Commentary: Valeant rebounds after subpoena-related slide, oils firm with crude prices; AMD gains despite losses
|
| 10/15/2015 | HY | Market Commentary: Valeant sours on subpoena, Fortescue up on debt buyback, cost cuts; funds gain $1.48 billion in week
|
| 10/15/2015 | HY | Market Commentary: Valeant falls on federal probe, oils off with crude; Fortescue gains on debt buyback, cost-cutting
|
| 10/15/2015 | HY | Market Commentary: Junk opens with firm tone; Valeant falls on subpoena news; Fortescue rises on production, guidance
|
| 10/5/2015 | HY | Market Commentary: High-yield bonds rebound as week begins; Valeant paper fades; Cablevision, Altice climb higher
|
| 10/2/2015 | HY | Market Commentary: Quiet primary ends week with no dollar pricings; recent deals firmer; Wynn up on China’s Macau move
|
| 10/1/2015 | HY | Market Commentary: Morning Commentary: Junk opens unchanged; Chesapeake bonds drop on ‘amendment’ news
|
| 9/29/2015 | HY | Market Commentary: Valeant rebounds; Alcoa finishes weak again; Chesapeake announces layoffs; Bombardier firms
|
| 9/29/2015 | CLHY | Market Commentary: Universal Fiber hikes talk on second-lien loan; chemical names softer; outflows on Monday
|
| 9/28/2015 | CLHY | Market Commentary: Loans down ¼ point Monday; Schumacher allocates; MedImpact, GTT Communications set meetings
|
| 9/28/2015 | HY | Market Commentary: High-yield market ends in ‘bloodbath’; recent new issues pressured; Valeant facing subpoena
|
| 9/25/2015 | HY | Market Commentary: Cablevision, Olin megadeals price to close out $11.4 billion week; new Iron Mountain trades busily
|
| 9/24/2015 | HY | Market Commentary: Iron Mountain, Beacon Roofing price, firm despite market sell-off; funds gain $17.7 million
|
| 9/11/2015 | HY | Market Commentary: Giant-sized Frontier three-parter, plus HealthSouth, Allegion price to cap $8.7 billion week
|
| 8/20/2015 | HY | Market Commentary: No pricings, primary seen done for summer; new KIK, Oneok notes active; funds gain $111 million
|
| 6/25/2015 | HY | Market Commentary: TI Automotive prices; Endo megadeal adds to gains; Valeant off on M&A; funds up $621 million
|
| 6/16/2015 | HY | Market Commentary: Upsized Radian Group prices; TI Automotive slates; Ashland plans debt offering; market mixed
|
| 5/22/2015 | CLHY | Market Commentary: Calpine, ClubCorp, Valeant Pharmaceuticals free to trade; LightSquared changes surface
|
| 5/20/2015 | CLHY | Market Commentary: Energizer, Kronos break; Virgin Media, Valeant, Infiltrator, Flint, TouchTunes tweak deals
|
| 5/14/2015 | CLHY | Market Commentary: CHS, Presidio, Ranpak, Acrisure break; Virgin, ClubCorp, Valeant, Connolly, Varsity launch
|
| 5/13/2015 | CLHY | Market Commentary: PetSmart, TransDigm, Arcade/Bioplan break; Aria, Ranpak update deals; CHG tweaks deadline
|
| 5/13/2015 | HY | Market Commentary: Hexion, Guitar Center firm on earnings; Nortel weakens on allocation plan; health care active
|
| 4/9/2015 | HY | Market Commentary: Fiat Chrysler, Murray megadeals lead $6.6 billion primary; Halcon up; funds gain $1.35 billion
|
| 4/2/2015 | BKCVHY | S&P lifts Valeant secured debt
|
| 4/1/2015 | CLHY | Market Commentary: Penn Products, Nortek break; CPM, Advantage Sales updates deals; Natel EMS shutting early
|
| 4/1/2015 | CAHYLM | Valeant to redeem Salix’s 6% senior notes due 2021 in two stages
|
| 3/20/2015 | HY | Market Commentary: Quiet primary wraps $4.8 billion week; more heavy trading in Rite Aid; Transocean tumbles again
|
| 3/19/2015 | HY | Market Commentary: Rite Aid, Sensata price deals; new Rite Aid rises; Guitar Center gains; funds lose $1 billion
|
| 3/18/2015 | HY | Market Commentary: Infor megadeal prices; Rite Aid, Huntsman slate; still-accommodative Fed helps market firm
|
| 3/17/2015 | HY | Market Commentary: Virgin Media, split-rated Masco deals price, Fortescue shelves offering; energy still fading
|
| 3/16/2015 | HY | Market Commentary: Vulcan drives by; new Valeant bonds busy as Endo gives up on Salix; energy slide continues
|
| 3/13/2015 | HY | Market Commentary: Giant-sized Valeant deal caps nearly $16 billion week, new bonds busy; energy names slide
|
| 3/13/2015 | CLHY | Market Commentary: Valeant Pharmaceuticals, Lions Gate Entertainment, Ferrara Candy break; Fortescue weakens
|
| 3/13/2015 | CAHY | New Issue: Valeant prices upsized $10 billion equivalent of notes in four parts
|
| 3/12/2015 | HY | Market Commentary: United Rentals, CenturyLink, Reliance deals price; Valeant upsizes; funds lose $1.96 billion
|
| 3/12/2015 | CLHY | Market Commentary: Ineos, Headwaters, Tank, Surgical Care hit secondary; Valeant, Wabash National modify deals
|
| 3/12/2015 | CAHY | Valeant Pharmaceuticals upsizes four-part bond deal to $10 billion, downsizes bank loan
|
| 3/12/2015 | CAHY | Valeant talks $9.6 billion equivalent four-part notes offering; commitments due 5 p.m. ET Thursday
|
| 3/11/2015 | HY | Market Commentary: Shea Homes two-parter, Surgical Care, GFL deals price; Valeant up on Endo bid for Salix
|
| 3/10/2015 | HY | Market Commentary: Tronox, KCG deals price; Monday deals trade actively; overall market lower
|
| 3/10/2015 | BKCAHY | Moody's rates Valeant loans Ba1, notes B1
|
| 3/10/2015 | BKCAHY | S&P provides B to Valeant notes
|
| 3/9/2015 | HY | Market Commentary: Crestwood, Masonite, HealthSouth drive by; calendar builds massively; Whiting jumps on sale talk
|
| 3/9/2015 | CLHY | Market Commentary: Coinmach frees to trade; Tank Holding, Surgical Care revisions revealed; Valeant sets talk
|
| 3/9/2015 | HY | Valeant Pharmaceuticals kicks off $9.6 billion equivalent four part deal; investor call Tuesday
|
| 3/9/2015 | BKCAHY | S&P gives BB to Valeant loans
|
| 3/5/2015 | CLHY | Market Commentary: Valeant kicks off $5.55 billion; Fortescue meeting Friday; funds see $196 million outflows
|
| 2/27/2015 | HY | Market Commentary: Bombardier upsizes drive-by megadeal, Riverbed, Nathan’s also price to cap $6.6 billion week
|
| 2/24/2015 | HY | Market Commentary: Digicel drives by, moves up; recent bonds busy; Sitel bonds gain as Onex eyes possible sale
|
| 2/23/2015 | HY | Market Commentary: DISH weakens after numbers, CEO retirement; Salix gains on Valeant merger; Toys’ bonds push up
|
| 2/23/2015 | CLHY | Market Commentary: Valeant dips, Ocwen up in trading; Riverbed, National Mentor, Armacell, Constantia revised
|
| 2/23/2015 | BKHY | S&P puts Valeant on positive watch
|
| 2/23/2015 | BKCAHY | Valeant plans $15.15 billion of term loans and notes for Salix buy
|
| 1/20/2015 | HY | Market Commentary: Post-holiday primary cooks with Zayo, Endo and HealthSouth drive-bys; new, recent deals busy
|
| 1/16/2015 | HY | Market Commentary: Dollar primary quiet to close $6 billion week, Europe active; Bombardier off again, Caesars up
|
| 1/15/2015 | HY | Market Commentary: Valeant, Targa price megadeals; Bombardier drops on plane pause; funds gain $879.5 million
|
| 1/15/2015 | CAHY | New Issue: Valeant Pharmaceuticals prices $1 billion eight-year notes at par to yield 5½%
|
| 1/15/2015 | BKCAHY | Moody’s rates Valeant notes B1, view positive
|
| 1/15/2015 | BKHY | S&P rates Valeant notes B
|
| 1/15/2015 | CAHYLM | Valeant Pharmaceuticals calls $499.58 million 6 7/8% notes in full
|
| 1/15/2015 | CAHY | Valeant Pharmaceuticals to price $1 billion eight-year notes Thursday
|
| 1/9/2015 | HY | Market Commentary: Morning Commentary: Better buyers push bonds up ½ point Friday morning; energy names unchanged
|
| 1/8/2015 | BKBWCAHYLMLW | Valeant cuts leverage to 3.5x, holds out prospect of more debt paydowns
|
| 12/1/2014 | HYLM | Valeant Pharmaceuticals calls $445 million 6 7/8% senior notes due 2018
|
| 11/21/2014 | BKCAHY | Moody’s revises Valeant to stable
|
| 11/20/2014 | HYLM | Valeant to buy back up to $2 billion of notes under repurchase program
|
| 9/15/2014 | HYLM | Valeant calls in full $500 million 6¾% notes for Oct. 15 redemption
|
| 8/18/2014 | HY | Market Commentary: Primary remains quiet although calendar builds; market mostly firmer, NII bonds continue rebound
|
| 6/18/2014 | HY | Market Commentary: West megadeal, NuvoTV, Wave Division offerings price; Valeant plans massive deal
|
| 6/18/2014 | BKHY | Valeant plans $7 billion loans, $12.35 billion bonds for Allergan bid
|
| 4/22/2014 | BKHY | Moody's revises Valeant outlook to developing
|
| 1/22/2014 | CVHY | Valeant to redeem up to $1.5 billion of notes under repurchase program
|
| 1/7/2014 | BKHYLM | Valeant Pharmaceuticals reiterates 2013 guidance, eyes 40% increase in 2014
|
| 12/5/2013 | BKCVHY | S&P rates Valeant loan BB
|
| 12/2/2013 | HYLM | Valeant Pharmaceuticals calls remaining $465.5 million 61/2% notes
|
| 11/18/2013 | HY | Market Commentary: T-Mobile, Sabine Pass megadeals drive by; calendar builds; ServiceMaster gyrates on spinoff plans
|
| 11/15/2013 | BKHY | S&P assigns Valeant notes B
|
| 11/15/2013 | HYLM | Valeant plans to call 61/2% senior notes due 2016 via new issue proceeds
|
| 11/15/2013 | BKHY | Moody's gives Valeant notes B1
|
| 11/15/2013 | CAHY | New Issue: Valeant Pharmaceuticals sells upsized $900 million 5 5/8% eight-year notes at par
|
| 11/15/2013 | CAHY | Valeant Pharmaceuticals selling $850 million eight-year senior notes in Friday drive-by
|
| 11/15/2013 | HY | Market Commentary: Upsized Valeant drive-by deal caps $9.1 billion week; new CenturyLink notes, Caesars active
|
| 11/15/2013 | HYLM | Valeant calls $450 million 61/2% notes due 2016 via new issue proceeds
|
| 9/10/2013 | BKHY | S&P rates Valeant loans BB
|
| 8/14/2013 | HY | Market Commentary: Primary returns with T-Mobile, NuStar, Access Midstream deals; AMR anti-merger slide continues
|
| 8/8/2013 | HY | Market Commentary: Iron Mountain leads $1.4 billion session; Penney gyrates on CEO talk; funds gain $486 million
|
| 8/7/2013 | HY | Market Commentary: Upsized BMC megadeal leads $2.6 billion session, rises in trading; SandRidge up on numbers
|
| 7/11/2013 | HY | Market Commentary: Quiksilver, Post lead return of dollar-deal market; overall junk firmer; funds up $12 million
|
| 7/9/2013 | HY | Market Commentary: Fiat, Continental lead European pricing parade; Quiksilver shops two-part dollar deal
|
| 7/8/2013 | HY | Market Commentary: RKI, Continental deals slate but Technicolor pulled; Sprint Nextel off on Softbank downgrade
|
| 7/3/2013 | HY | Market Commentary: Midday Commentary: ETF flows negative; sanguine credit picture fails to dispel bearish sentiment
|
| 7/2/2013 | HY | Market Commentary: Domestic primary stays quiet; Europe sees FTE deal hit the road; Linn Energy off on SEC probe
|
| 7/1/2013 | HY | Market Commentary: Midday Commentary: Despite outflows, junk regaining some traction; week opens to slim calendar
|
| 7/1/2013 | HY | Market Commentary: High-yield primary quiets down as holiday run-up starts; secondary levels seen better
|
| 6/28/2013 | HY | Market Commentary: Hercules, PetroQuest, Creditcorp cap nearly $6 billion week; new Valeant notes stay strong
|
| 6/27/2013 | HY | New Issue: Valeant Pharmaceuticals prices $3.225 billion notes in two tranches
|
| 6/27/2013 | HY | Market Commentary: Valeant megadeal, Solera drive-by price; new Valeant paper jumps; funds slide by $3.1 billion
|
| 6/26/2013 | HY | Market Commentary: No pricings, but market awaits Valeant deal; Nord Anglia add-on slates; better tone continues
|
| 6/25/2013 | CAHY | Valeant sets price talk for restructured $3.2 billion two-part deal
|
| 6/25/2013 | HY | Market Commentary: TransDigm, Gibson break junk debt drought; Valeant restructures megadeal; market seems better
|
| 6/24/2013 | HY | Market Commentary: No pricings, but Hercules slates deal; Vanguard Health Systems up; Tenet down on merger news
|
| 6/21/2013 | HY | Market Commentary: Junk market steadies but wary after Thursday slide; American Equity, Intralot deals postponed
|
| 6/19/2013 | BKCVHY | S&P lowers Valeant, rates new term loans BB, notes B
|
| 6/19/2013 | BKCVHY | Moody's: Valeant notes B1, loans Ba1
|
| 6/19/2013 | CAHY | Valeant Pharmaceuticals plans roadshow for $3.2 billion two-part notes
|
| 6/19/2013 | HY | Market Commentary: National Financial, AK Steel price; new Rite Aid struggles; market wary after Bernanke
|
| 5/31/2013 | BKHY | Valeant Pharmaceuticals gets $9.28 billion bridge loan commitment
|
| 5/30/2013 | BKHY | Valeant holds lender call, reveals expected financing for Bausch buy
|
| 5/28/2013 | BKHY | S&P: Valeant Pharmaceuticals on negative watch
|
| 5/28/2013 | BKHY | Moody's affirms Valeant
|
| 5/28/2013 | BKHY | Valeant Pharmaceuticals plans loans, bonds for Bausch + Lomb buy
|
| 2/12/2013 | BKCAHY | S&P rates Valeant loans BBB-
|
| 1/17/2013 | BKCVHY | S&P rates Valeant loan BBB-
|
| 1/4/2013 | BKCAHY | Valeant Pharmaceuticals targets revenue of up to $4.8 billion, 35% increase in EPS for 2013
|
| 11/19/2012 | CAHYLM | Valeant buys back C$89.9 million three senior note series at discount
|
| 9/24/2012 | HY | Market Commentary: Gray TV, Frontier, Ply Gem, BreitBurn price; calendar builds; Calpine terminates deal
|
| 9/21/2012 | HY | Market Commentary: Sotheby's, Glatfelter, Air Lease price to cap off $12 billion week; Sotheby's, SBA bonds move up
|
| 9/20/2012 | HY | Market Commentary: Valeant, Rockwood mega-deals pace nearly $6 billion session; funds post $1.36 billion gain
|
| 9/20/2012 | CAHY | Valeant restructures $2.25 billion notes offer, sets price talk
|
| 9/19/2012 | CAHY | Valeant Pharmaceuticals intends to price $2.25 billion of notes in three parts on Thursday
|
| 9/19/2012 | CAHY | Valeant Pharmaceuticals selling $2.25 billion of notes in three parts
|
| 9/19/2012 | HY | Market Commentary: Nationstar, AOT deals price, move up, Hovnanian, Intelsat also drive by; calendar swells
|
| 9/13/2012 | BKCAHY | Moody's rates Valeant loan Ba1, notes B1
|
| 9/7/2012 | BKCAHY | S&P rates Valeant loan BBB-, notes BB-
|
| 9/7/2012 | BKCAHY | Valeant's acquisition of Medicis expected to generate $1.75 billion bonds, $1 billion term loan
|
| 9/5/2012 | BKCAHY | S&P affirms Valeant
|
| 9/4/2012 | BKCAHY | Moody's could cut Valeant
|
| 9/4/2012 | BKHY | Valeant gets $2.75 billion bridge commitment, plans term loan, bonds
|
| 6/29/2012 | BKCAHY | S&P rates Valeant loan BBB-
|
| 6/5/2012 | BKCACVHY | S&P rates Valeant loan BBB-
|
| 6/5/2012 | BKCAHY | Moody's says Valeant debt is credit negative
|
| 1/31/2012 | BKCAHY | S&P rates Valeant loan BBB-
|
| 1/30/2012 | BKCACVHY | Moody's rates Valeant loan Ba1
|
| 1/6/2012 | BKCAHY | Valeant gives cash flow guidance of roughly $1.2 billion for 2012
|
| 11/3/2011 | CACVHYLM | Valeant Pharmaceuticals reports double-digit growth, ends Q3 with $5.6 billion of debt
|
| 11/3/2011 | CACVHYLM | Valeant resumes buyback program for convertibles, notes and other debt
|
| 9/28/2011 | BKCAHY | S&P ups Valeant, rates loans
|
| 9/28/2011 | BKCAHY | Moody's: Valeant notes Baa3
|
| 9/15/2011 | CACVHYLM | Valeant eyes growth in Europe; cash flow from operations could hit $900 million in 2012
|
| 8/29/2011 | CACVHYLM | Valeant increases securities repurchase program to C$1.8 billion
|
| 5/26/2011 | BKCAHY | S&P affirms Valeant
|
| 3/30/2011 | BKCACVHY | S&P puts Valeant on watch
|
| 3/30/2011 | BKCACVHY | Moody's may cut Valeant
|
| 3/29/2011 | BKHY | Valeant makes bid for Cephalon that would be all debt financed
|
| 3/4/2011 | HY | Market Commentary: Upsized Huntington Ingalls mega-deal, JMC Steel price, jump in trading to close out busy week
|
| 3/2/2011 | CAHY | Valeant sets talk on $1.5 billion two-part offering of senior notes
|
| 11/19/2010 | BKCACVHY | Moody's: Valeant unchanged
|
| 11/18/2010 | BKHY | Moody's upgrades Valeant loans, rates notes B1
|
| 11/4/2010 | CACVHYLM | Valeant to buy back $1.5 billion convertibles, senior notes, stock
|
| 9/21/2010 | CAHY | New Issue: Valeant upsizes to $1.2 billion, prices seven-, 10-year senior notes
|
| 9/21/2010 | HY | Market Commentary: Valeant, Tomkins mega-deals pace nearly $3 billion primary session; new Tomkins bonds trade up
|
| 9/17/2010 | HY | Market Commentary: Primary subdued despite Visant, RAAM pricings; secondary firm but quiet as new issues level off
|
| 9/17/2010 | CAHY | Valeant Pharmaceuticals sets talk for $1 billion two-part note sale
|
| 9/16/2010 | HY | Valeant to sell $1 billion senior notes in seven-, 10-year tranches
|
| 9/9/2010 | CAHY | Valeant to start roadshow Wednesday for $1 billion senior notes
|
| 9/9/2010 | HY | Market Commentary: New bonds take focus; MetroPCS, Alliant still busy; Edison Mission up; funds add $645 million
|
